4
brands
Rapid Acting Insulin
Insulin Aspart
Type 1 DM
Clinical discovery
Browse by indication
Explore generic medicines by their listed indication information in this reference database.
Reference information only.
Indications describe information stored for each generic.
They are not a diagnosis, treatment recommendation or
substitute for professional medical advice.
1
brand
Long Acting Insulin
Insulin Degludec
Type 1 DM
2
brands
Combination Insulin
Insulin Degludec + Insulin Aspart Premixed
Type 1 DM
1
brand
Long Acting Insulin
Insulin Detemir
Type 1 DM
15
brands
Long Acting Insulin
Insulin Glargine [rDNA]
Type 1 DM
2
brands
Rapid Acting Insulin
Insulin Glulisine
Type 1 DM
22
brands
Rapid Acting Insulin
Insulin Human [Fast-Acting]
Type 1 DM
21
brands
Long Acting Insulin
Insulin Human [Long-Acting]
Type 1 DM
32
brands
Medium Acting Insulin
Insulin Human [rDNA] + Isophane Insulin Human
Type 1 DM
3
brands
Rapid Acting Insulin
Insulin Lispro
Type 1 DM
4
brands
Combination Insulin
Insulin Lispro Protamine + Insulin Lispro
Type 1 DM
10
brands
Rapid Acting Insulin
Protamine Crystallised Insulin Aspart
Type 1 DM
5
brands
Alpha-Glucosidase inhibitor
Acarbose
Type 2 DM
Alogliptin Benzoate
Type 2 DM
Canagliflozin Hemihydrate
Type 2 DM
Dapagliflozin Propanediol
Type 2 DM
2
brands
GLP-1 receptor agonists
Dulaglutide
Type 2 DM
Empagliflozin
Type 2 DM
Empagliflozin + Metformin Hydrochloride
Type 2 DM
Ertugliflozin
Type 2 DM
5
brands
Sulfonylureas
Glibenclamide
Type 2 DM
106
brands
Sulfonylureas
Gliclazide
Type 2 DM
94
brands
Sulfonylureas
Glimepiride
Type 2 DM
Glimepiride + Metformin
Type 2 DM
7
brands
Sulfonylureas
Glipizide
Type 2 DM
Glipizide + Metformin Hydrochloride
Type 2 DM
2
brands
Rapid Acting Insulin
Insulin Aspart + Insulin Aspart Protamine
Type 2 DM
38
brands
Dipeptidyl Peptidase-4 (DPP-4) inhibitor
Linagliptin
Type 2 DM
Linagliptin + Metformin Hydrochloride
Type 2 DM
1
brand
GLP-1 receptor agonists
Liraglutide
Type 2 DM